LASA SUPERGENERICS
Back to Balance Sheet
|
LASA SUPERGENERICS Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹49 Cr | ₹43 Cr | ₹45 Cr | ₹41 Cr | ₹76 Cr |
What is the latest Total Current Liabilities ratio of LASA SUPERGENERICS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2024 | ₹49 Cr |
| Mar2023 | ₹43 Cr |
| Mar2022 | ₹45 Cr |
| Mar2021 | ₹41 Cr |
| Mar2020 | ₹76 Cr |
How is Total Current Liabilities of LASA SUPERGENERICS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹49 Cr | 14.38 | |
| Mar2023 | ₹43 Cr | -4.52 | |
| Mar2022 | ₹45 Cr | 10.40 | |
| Mar2021 | ₹41 Cr | -46.61 | |
| Mar2020 | ₹76 Cr | - | |
Compare Total Current Liabilities of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹38.7 Cr | -2.4% | -5% | -55.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,121.0 Cr | 3.2% | 12.5% | 10.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,396.0 Cr | 2.9% | 8.5% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,730.0 Cr | 0.3% | 5.7% | 36.3% | Stock Analytics | |
| CIPLA | ₹115,241.0 Cr | 10.4% | 15.9% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,126.0 Cr | 4.8% | 9% | 10.8% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | -2.4% |
-5% |
-55.2% |
| SENSEX | -0.9% |
-3.6% |
-8.6% |
You may also like the below Video Courses